Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER: Multicenter Retrospective Study (Real World Evidence - RWE)

NCT05945108 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05945108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER: Multicenter Retrospective Study (Real World Evidence - RWE)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 10, 2023
Completion date
April 18, 2024
Enrollment
400 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

muscle-invasive bladder cancer, non muscle invasive bladder cancer, urothelial carcinoma